Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Liquidia Co. stock logo
LQDA
Liquidia
$12.53
+1.3%
$14.55
$5.71
$16.99
$952.66M0.16949,572 shs527,417 shs
Pro-Dex, Inc. stock logo
PDEX
Pro-Dex
$18.42
-0.2%
$17.67
$14.51
$22.99
$64.65M0.67,894 shs6,402 shs
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
$3.41
+2.4%
$3.82
$1.79
$5.38
$55.89M0.91144,133 shs47,636 shs
STRATA Skin Sciences, Inc. stock logo
SSKN
STRATA Skin Sciences
$0.51
-1.9%
$0.50
$0.26
$1.14
$18.04M1.5831,517 shs7,595 shs
Beginners Guide To Retirement Stocks Cover

Click the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Liquidia Co. stock logo
LQDA
Liquidia
-1.43%-10.43%-22.30%+1.64%+82.99%
Pro-Dex, Inc. stock logo
PDEX
Pro-Dex
-0.22%-1.70%+7.20%-14.22%+15.52%
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
+1.52%+2.46%-16.54%-5.67%-28.85%
STRATA Skin Sciences, Inc. stock logo
SSKN
STRATA Skin Sciences
-5.50%+4.79%+15.04%+1.75%-44.88%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Liquidia Co. stock logo
LQDA
Liquidia
2.2402 of 5 stars
3.31.00.00.02.14.20.6
Pro-Dex, Inc. stock logo
PDEX
Pro-Dex
N/AN/AN/AN/AN/AN/AN/AN/A
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
2.6289 of 5 stars
3.53.00.00.02.70.81.3
STRATA Skin Sciences, Inc. stock logo
SSKN
STRATA Skin Sciences
1.2514 of 5 stars
2.04.00.00.02.51.70.6

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Liquidia Co. stock logo
LQDA
Liquidia
2.60
Moderate Buy$21.0067.60% Upside
Pro-Dex, Inc. stock logo
PDEX
Pro-Dex
N/AN/AN/AN/A
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
3.00
Buy$7.50119.94% Upside
STRATA Skin Sciences, Inc. stock logo
SSKN
STRATA Skin Sciences
N/AN/A$3.80638.58% Upside

Current Analyst Ratings

Latest SSKN, LQDA, SRTS, and PDEX Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
4/10/2024
Liquidia Co. stock logo
LQDA
Liquidia
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$28.00
4/1/2024
Liquidia Co. stock logo
LQDA
Liquidia
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$28.00
3/14/2024
Liquidia Co. stock logo
LQDA
Liquidia
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$16.00 ➝ $32.00
3/13/2024
Liquidia Co. stock logo
LQDA
Liquidia
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$28.00
2/21/2024
Liquidia Co. stock logo
LQDA
Liquidia
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$28.00
(Data available from 4/26/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Liquidia Co. stock logo
LQDA
Liquidia
$17.49M54.47N/AN/A$0.73 per share17.16
Pro-Dex, Inc. stock logo
PDEX
Pro-Dex
$46.09M1.40$2.23 per share8.26$8.91 per share2.07
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
$24.41M2.29$0.06 per share56.80$2.98 per share1.14
STRATA Skin Sciences, Inc. stock logo
SSKN
STRATA Skin Sciences
$33.36M0.54N/AN/A$0.37 per share1.39

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Liquidia Co. stock logo
LQDA
Liquidia
-$78.50M-$1.20N/AN/AN/A-448.89%-132.16%-65.35%5/2/2024 (Estimated)
Pro-Dex, Inc. stock logo
PDEX
Pro-Dex
$7.07M$0.7524.56N/A5.59%8.97%5.40%5/2/2024 (Estimated)
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
$490K$0.03113.70N/A1.99%1.04%0.93%5/9/2024 (Confirmed)
STRATA Skin Sciences, Inc. stock logo
SSKN
STRATA Skin Sciences
-$10.83M-$0.31N/AN/AN/A-32.47%-52.50%-17.66%5/20/2024 (Estimated)

Latest SSKN, LQDA, SRTS, and PDEX Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/9/2024N/A
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
-$0.04N/A+$0.04N/AN/AN/A  
3/27/2024Q4 2023
STRATA Skin Sciences, Inc. stock logo
SSKN
STRATA Skin Sciences
N/A-$0.04-$0.04$0.03N/A$8.69 million
3/13/2024Q4 2023
Liquidia Co. stock logo
LQDA
Liquidia
-$0.23-$0.42-$0.19-$0.42$5.29 million$4.53 million
2/8/2024Q2 2024
Pro-Dex, Inc. stock logo
PDEX
Pro-Dex
N/A$0.14+$0.14$0.14N/A$12.59 million
2/8/2024Q4 2023
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
$0.12$0.26+$0.14$0.26$12.10 million$12.57 million

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Liquidia Co. stock logo
LQDA
Liquidia
N/AN/AN/AN/AN/A
Pro-Dex, Inc. stock logo
PDEX
Pro-Dex
N/AN/AN/AN/AN/A
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
N/AN/AN/AN/AN/A
STRATA Skin Sciences, Inc. stock logo
SSKN
STRATA Skin Sciences
N/AN/AN/AN/AN/A

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Liquidia Co. stock logo
LQDA
Liquidia
N/A
4.85
4.85
Pro-Dex, Inc. stock logo
PDEX
Pro-Dex
0.26
3.66
2.16
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
N/A
11.76
8.23
STRATA Skin Sciences, Inc. stock logo
SSKN
STRATA Skin Sciences
1.19
1.28
1.06

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Liquidia Co. stock logo
LQDA
Liquidia
64.54%
Pro-Dex, Inc. stock logo
PDEX
Pro-Dex
15.28%
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
25.30%
STRATA Skin Sciences, Inc. stock logo
SSKN
STRATA Skin Sciences
32.43%

Insider Ownership

CompanyInsider Ownership
Liquidia Co. stock logo
LQDA
Liquidia
31.60%
Pro-Dex, Inc. stock logo
PDEX
Pro-Dex
42.60%
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
11.10%
STRATA Skin Sciences, Inc. stock logo
SSKN
STRATA Skin Sciences
40.43%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Liquidia Co. stock logo
LQDA
Liquidia
14576.03 million52.00 millionOptionable
Pro-Dex, Inc. stock logo
PDEX
Pro-Dex
1453.51 million2.02 millionNot Optionable
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
3516.39 million14.57 millionOptionable
STRATA Skin Sciences, Inc. stock logo
SSKN
STRATA Skin Sciences
9935.06 million20.89 millionNot Optionable

SSKN, LQDA, SRTS, and PDEX Headlines

SourceHeadline
Strata Skin Sciences to Effect a 1-for-10 Reverse Stock SplitStrata Skin Sciences to Effect a 1-for-10 Reverse Stock Split
marketwatch.com - April 26 at 9:05 PM
STRATA Skin Sciences Announces 1-for-10 Reverse Stock SplitSTRATA Skin Sciences Announces 1-for-10 Reverse Stock Split
globenewswire.com - April 26 at 5:20 PM
STRATA Skin Sciences to Present at the Planet MicroCap Showcase: Vegas 2024STRATA Skin Sciences to Present at the Planet MicroCap Showcase: Vegas 2024
globenewswire.com - April 23 at 8:30 AM
STRATA Skin Sciences (NASDAQ:SSKN) Share Price Crosses Above 200 Day Moving Average of $0.52STRATA Skin Sciences (NASDAQ:SSKN) Share Price Crosses Above 200 Day Moving Average of $0.52
americanbankingnews.com - April 23 at 3:20 AM
STRATA Skin Sciences (SSKN) Price Target Increased by 32.61% to 3.11STRATA Skin Sciences (SSKN) Price Target Increased by 32.61% to 3.11
msn.com - April 18 at 12:46 AM
STRATA Skin Sciences Bolsters International Presence with Renewed Distribution Agreements in AsiaSTRATA Skin Sciences Bolsters International Presence with Renewed Distribution Agreements in Asia
msn.com - April 10 at 7:44 PM
STRATA Skin Sciences, Inc.: STRATA Skin Sciences Announces Renewal of Exclusive Distribution Agreements in China and JapanSTRATA Skin Sciences, Inc.: STRATA Skin Sciences Announces Renewal of Exclusive Distribution Agreements in China and Japan
finanznachrichten.de - April 9 at 2:16 PM
STRATA Skin Sciences Announces Renewal of Exclusive Distribution Agreements in China and JapanSTRATA Skin Sciences Announces Renewal of Exclusive Distribution Agreements in China and Japan
globenewswire.com - April 9 at 8:30 AM
STRATA Skin Sciences, Inc. (NASDAQ:SSKN) Q4 2023 Earnings Call TranscriptSTRATA Skin Sciences, Inc. (NASDAQ:SSKN) Q4 2023 Earnings Call Transcript
finance.yahoo.com - April 1 at 7:34 PM
STRATA Skin Sciences Unveils 2023 Financial Results: A Look into an Evolving Business ModelSTRATA Skin Sciences Unveils 2023 Financial Results: A Look into an Evolving Business Model
msn.com - March 31 at 6:32 PM
STRATA Skin Sciences, Inc.: STRATA Skin Sciences Reports Fourth Quarter and Full-Year 2023 EarningsSTRATA Skin Sciences, Inc.: STRATA Skin Sciences Reports Fourth Quarter and Full-Year 2023 Earnings
finanznachrichten.de - March 29 at 3:08 PM
Earnings Preview For Strata Skin SciencesEarnings Preview For Strata Skin Sciences
benzinga.com - March 28 at 10:35 PM
Q4 2023 STRATA Skin Sciences Inc Earnings CallQ4 2023 STRATA Skin Sciences Inc Earnings Call
finance.yahoo.com - March 28 at 8:26 AM
Recap: Strata Skin Sciences Q4 EarningsRecap: Strata Skin Sciences Q4 Earnings
benzinga.com - March 27 at 5:25 PM
STRATA Skin Sciences Reports Fourth Quarter and Full-Year 2023 EarningsSTRATA Skin Sciences Reports Fourth Quarter and Full-Year 2023 Earnings
globenewswire.com - March 27 at 4:01 PM
STRATA Skin Sciences to Report Fourth Quarter and Full-Year 2023 Financial Results on March 27, 2024STRATA Skin Sciences to Report Fourth Quarter and Full-Year 2023 Financial Results on March 27, 2024
globenewswire.com - March 13 at 8:00 AM
Spearheading Change in Dermatology: STRATA Pushes for Expanded Insurance Coverage of Vital Skin TreatmentsSpearheading Change in Dermatology: STRATA Pushes for Expanded Insurance Coverage of Vital Skin Treatments
msn.com - March 11 at 6:59 PM
STRATA Skin Sciences Announces Initiative to Expand Treatment CoverageSTRATA Skin Sciences Announces Initiative to Expand Treatment Coverage
globenewswire.com - March 7 at 8:00 AM
SSKN STRATA Skin Sciences, Inc.SSKN STRATA Skin Sciences, Inc.
seekingalpha.com - March 3 at 12:43 PM
STRATA Skin Sciences Successfully Amends Credit Agreement, Bolstering Strategic InitiativesSTRATA Skin Sciences Successfully Amends Credit Agreement, Bolstering Strategic Initiatives
msn.com - February 29 at 2:54 PM
STRATA Skin Sciences, Inc.: STRATA Skin Sciences Announces Successful Amendment to Credit Agreement with MidCap FinancialSTRATA Skin Sciences, Inc.: STRATA Skin Sciences Announces Successful Amendment to Credit Agreement with MidCap Financial
finanznachrichten.de - February 27 at 10:35 AM
STRATA Skin Sciences Announces Successful Amendment to Credit Agreement with MidCap FinancialSTRATA Skin Sciences Announces Successful Amendment to Credit Agreement with MidCap Financial
globenewswire.com - February 26 at 4:01 PM
Strata Skin Sciences Inc SSKNStrata Skin Sciences Inc SSKN
morningstar.com - February 22 at 7:35 AM
STRATA Skin Sciences, Inc. (NASDAQ:SSKN): Are Analysts Optimistic?STRATA Skin Sciences, Inc. (NASDAQ:SSKN): Are Analysts Optimistic?
finance.yahoo.com - January 11 at 10:36 AM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Company Descriptions

Liquidia logo

Liquidia

NASDAQ:LQDA
Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its lead product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD). The company also offers Remodulin, a treprostinil administered through continuous intravenous and subcutaneous infusion. The company also a license agreement with Pharmosa Biopharm Inc to develop and commercialize L606, an inhaled sustained-release formulation of Treprostinil for the treatment of PAH and PH-ILD. Liquidia Corporation was founded in 2004 and is headquartered in Morrisville, North Carolina.
Pro-Dex logo

Pro-Dex

NASDAQ:PDEX
Pro-Dex, Inc. designs, develops, manufactures, and sells powered surgical instruments for medical device original equipment manufacturers worldwide. The company offers autoclavable, battery-powered and electric, and multi-function surgical drivers and shavers that are primarily used in the orthopedic, thoracic, and craniomaxillofacial markets. It also provides engineering, quality, and regulatory consulting services; and manufactures and sells rotary air motors to various industries. The company's products are used in hospitals, medical engineering labs, scientific research facilities, and high-tech manufacturing operations. Pro-Dex, Inc. was founded in 1978 and is headquartered in Irvine, California.
Sensus Healthcare logo

Sensus Healthcare

NASDAQ:SRTS
Sensus Healthcare, Inc., a medical device company, manufactures and sells radiation therapy devices to healthcare providers worldwide. The company uses superficial radiation therapy, a low-energy X-ray technology in its portfolio of treatment devices. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers, as well as other skin conditions, such as keloids; and SRT-100 Vision, which provides the user with a superficial radiation therapy-tailored treatment planning application that integrates an embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and dosimetry parameters. The company also provides SRT-100 Plus; Sentinel service program, which offers its customers protection for their systems; and Transdermal Infusion system, a biophysical alternative to infuse high weight molecule modalities into the dermis for medical and aesthetic purposes without the use of needles. In addition, it sells disposable lead shielding replacements; and disposable radiation safety items, such as aprons and eye shields, ultrasound probe film, and disposable applicator tips to treat various sized lesions and various areas of the body. Further, the company distributes laser devices, which includes applications for hair removal, vascular lesions, acne treatment, skin toning, and skin rejuvenation, as well as epidermal pigment removal for spots, freckles, and tattoos. It markets its products primarily to private dermatology practices, and radiation oncologists in both private and hospital settings. Sensus Healthcare, Inc. was incorporated in 2010 and is headquartered in Boca Raton, Florida.
STRATA Skin Sciences logo

STRATA Skin Sciences

NASDAQ:SSKN
STRATA Skin Sciences, Inc., a medical technology company, develops, commercializes, and markets products for the treatment of dermatologic conditions in the United States, Europe, the Middle East, Asia, Australia, South Africa, and Central and South America. The company operates in two segments, Dermatology Recurring Procedures and Dermatology Procedures Equipment. The company products include XTRAC and Pharos excimer lasers, and VTRAC lamp systems for the treatment systems that are used for the treatment of psoriasis, vitiligo, and other skin conditions. It also offers TheraClear Acne Therapy System for the treatment of mild to moderate inflammatory, comedonal, and pustular acne. The company was formerly known as MELA Sciences, Inc and changed its name to STRATA Skin Sciences, Inc. in January 2016. STRATA Skin Sciences, Inc. was incorporated in 1989 and is based in Horsham, Pennsylvania.